Module 9 2021

23/03/2021

Glossary

CMV

Cytomegalovirus

NCL

National Control Laboratory

CPP

Certificate of Pharmaceutical Product NRA

National Regulatory Authority

DTPa

Diphtheria-Tetanus-acellular Pertussis OMCL

Official Medicines Control Laboratory

EMP

Essential medicines and health products

UN

United Nations

EPI

Extended Programme on Immunisation

UNICEF United Nations International Children's Emergency Fund

FTIH First Time In Humans

PAHO Pan-American Health Organisation

HBS

Hepatitis B Surface antigen

PMS

Post-Marketing Surveillance

HBV

Hepatitis B Vaccine

PQ

Prequalification

HCV

Hepatitis C Vaccine

PQT

Prequalification Team (WHO)

Hib- MenC

Haemophilus influenzae b – Meningococcal Group C Health Systems and Innovation (WHO)

RHT

Regulation of medicines and other Health Technologies (Regulatory Dept. at WHO)

HIS

RSV

Respiratory Syncytial Virus

IPV

Inactivated Polio Vaccine

PSPQ

Programmatic Suitability for Prequalification

OPV

Oral Polio Vaccine

WHO

World Health Organisation

MMRV Measles Mumps Rubella Varicella

UMV

Universal Mass Vaccination

85

43